News

New Mexico Cancer Center uses latest technology to help detect prostate cancer
With a team of dedicated specialists, the New Mexico Cancer Center uses the latest technology, from blood tests and imaging ...
Healio21h
FDA expands darolutamide indication for advanced prostate cancer
The FDA has approved darolutamide without chemotherapy for treatment of metastatic hormone-sensitive prostate cancer.The FDA ...
Fierce Pharma23h
Bayer gains key FDA expansion for fast-rising prostate cancer drug Nubeqa
Bayer has taken another step toward achieving its €3 billion peak sales estimate for androgen receptor inhibitor Nubeqa, ...